Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi ® (tafasitamab) in combination with rituximab and lenalidomide for adult ...

Gabe Veltri, ‘24, and Olivia Roberts, ‘24, undergraduate research study makes it into scientific journal, Urban Ecosystems.

A child waits last year in the daycare at Faith Presbyterian Church for her mother to get out of an English language class for refugee women from Afghanistan. Such families are trying to do exactly ...

The 2025 Vega Digital Awards has unveiled the winners of its Season 2 competition, spotlighting outstanding achievements from creators and companies pushing the boundaries of digital media, ...

If Taiwan were to fall, Japan’s security architecture would be fundamentally compromised. The First Island Chain would fracture, opening a northern pathway for Beijing toward Okinawa and Kyushu.

Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Minjuvi ® (tafasitamab) in combination with lenalidomide and rituximab for the treatment of adult patients with ...